ResMed (RMD) free cash flow

Free cash flow · fiscal 2026
$1.63B

ResMed (RMD) generated free cash flow of $1.63B in fiscal 2026 (the year ended June 30, 2026). That is 1.4% lower than the $1.65B of fiscal 2025. Figures as of 18 Nov 2026, 12:07 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2026
$1.63B
Change on fiscal 2025
−1.4%
Growth, 5 years
+20.8% a year
Growth, 10 years
+12.8% a year
Highest on record
$1.65Bfiscal 2025
Lowest on record
$129.19Mfiscal 2009
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ResMed free cash flow, in more detail

Over the five fiscal years to 2026 free cash flow grew at a compound 20.8% a year; over ten years the rate was 12.8% a year. Across the 18 fiscal years on record (2009–2026), the highest was $1.65B in fiscal 2025 and the lowest $129.19M in fiscal 2009.

History · 18 fiscal years

Free cash flow by fiscal year

ResMed free cash flow, year by year

ResMed (RMD) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2026$1.63B 1.4% down
2025$1.65B 28.3% up
2024$1.29B 130.0% up
2023$559.30M 158.6% up
2022$216.31M 65.9% down
2021$634.01M 10.3% down
2020$706.93M 81.1% up
2019$390.34M 11.8% down
2018$442.45M 25.8% up
2017$351.83M 28.1% down
2016$489.40M 52.6% up
2015$320.68M 0.7% up
2014$318.55M 6.1% down
2013$339.24M 1.0% up
2012$336.02M 55.1% up
2011$216.58M 64.9% up
2010$131.36M 1.7% up
2009$129.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of ResMed and comparable companies
CompanyFree cash flowFiscal year
Genmab GMAB$1.13B2025
Illumina ILMN$931.00M2025
ResMed RMD$1.63B2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RMD

ResMed, figure by figure

ResMed (RMD) overview: price, valuation and scorecardAll health care companies by market value

ResMed free cash flow: questions and answers

What is ResMed's free cash flow?

ResMed (RMD) generated free cash flow of $1.63B in fiscal 2026 (the year ended June 30, 2026). That is 1.4% lower than the $1.65B of fiscal 2025.

What is the growth rate of ResMed's free cash flow?

Over the five fiscal years to 2026 free cash flow grew at a compound 20.8% a year; over ten years the rate was 12.8% a year.

What are the highest and lowest free cash flow figures on record for ResMed?

Across the 18 fiscal years on record (2009–2026), the highest was $1.65B in fiscal 2025 and the lowest $129.19M in fiscal 2009.

How is ResMed's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For ResMed it is on record here for 18 fiscal years, 2009 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ResMed (RMD) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/RMD/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.